{"id":2820,"date":"2026-08-24T23:14:13","date_gmt":"2026-08-24T23:14:13","guid":{"rendered":"https:\/\/officialcorepeptides.brandloom.net\/en\/?post_type=product&p=2820"},"modified":"2026-08-24T23:14:13","modified_gmt":"2026-08-24T23:14:13","slug":"buy-cortagen-20mg-in-switzerland","status":"publish","type":"product","link":"https:\/\/officialcorepeptides.ch\/en\/product\/buy-cortagen-20mg-in-switzerland\/","title":{"rendered":"Cortagen \u2013(20MG)"},"content":{"rendered":"

What Is Cortagen and Why Buy It for Research?<\/strong><\/h2>\n

Buy Cortagen 20mg in Switzerland for research into neuroprotection, central nervous system gene regulation, and tissue-specific bioregulation. Specifically, Cortagen (also known as AEDP or Ala-Glu-Asp-Pro) is a synthetic tetrapeptide composed of four amino acids with the sequence Ala-Glu-Asp-Pro (AEDP). Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology developed Cortagen through directed synthesis based on amino acid analysis of the natural brain cortex peptide preparation Cortexin.<\/p>\n

Cortagen is structurally similar to Epithalon (AEDG) but differs by one C-terminal residue, with proline replacing glycine, conferring distinct central nervous system tissue specificity. In scientific research, Cortagen serves as a molecular tool for studying tissue-specific gene expression regulation in neural and nervous system experimental systems.<\/p>\n

Researchers consider this peptide particularly valuable for investigating neuroprotective mechanisms, chromatin remodeling, and nerve regeneration. Furthermore, Core Peptides supplies Cortagen as a lyophilized powder in a 20mg format exclusively for laboratory use. Therefore, researchers seeking to source this compound for their work will find it readily available when they buy Cortagen 20mg in Switzerland.<\/p>\n

Cortagen Research Overview: Buy Cortagen 20mg in Switzerland for Neuroprotection Studies<\/strong><\/h2>\n

Centrally, research into Cortagen has focused on its function as a tissue-specific bioregulator targeting the brain and central nervous system. Researchers originally identified the peptide as a primary active component of Cortexin, a mixture of peptides derived from cow brain cortex tissue. The synthetic AEDP tetrapeptide was designed to reproduce the biological activity of these endogenous brain cortex peptide fragments.<\/p>\n

Unlike conventional pharmaceutical agents that act through receptor-mediated signaling, Khavinson’s bioregulator theory proposes that Cortagen penetrates cell nuclei and interacts directly with DNA and chromatin, thereby modulating transcription of tissue-relevant genes. Research has demonstrated that Cortagen induces deheterochromatinization (unrolling\/decondensation) of total heterochromatin and activates synthetic processes of ribosomal genes.<\/p>\n

This epigenetic regulation of “aged” heterochromatin is a key mechanism by which Cortagen is proposed to exert its effects. Notably, Cortagen has demonstrated a pronounced therapeutic effect upon the structural and functional posttraumatic recovery of peripheral nerve tissue in humans. Accordingly, researchers who buy Cortagen 20mg in Switzerland from Core Peptides can support their investigations into neuroprotection, gene expression regulation, and nervous system biology.<\/p>\n

How Does Cortagen Work in Research?<\/strong><\/h2>\n

Mechanistically, Cortagen’s proposed action involves functioning as a nuclear-targeting peptide that modulates gene expression through epigenetic chromatin remodeling. The peptide operates through several interconnected mechanisms.<\/p>\n

Chromatin Remodeling and Gene Activation<\/strong><\/h3>\n

Cortagen induces deheterochromatinization\u2014the unrolling and decondensation of heterochromatin\u2014effectively releasing locked genes for transcriptional activation. This process activates synthetic processes of ribosomal genes as a result of deheterochromatinization of satellite stalks of acrocentric chromosomes. Through this epigenetic regulation, Cortagen modulates gene expression patterns in a tissue-specific manner, upregulating regenerative pathways and downregulating inflammatory or stress-related pathways.<\/p>\n

Neuroprotective Activity<\/strong><\/h3>\n

Cortagen has been shown to protect brain tissue against ischemic damage in experimental models. Studies investigating the effect of Cortagen on the volume of cerebral cortex infarct area and on the dynamics of subsequent neurological deficits in rat stroke models indicate that Cortagen is a promising neuroprotective agent. Furthermore, the peptide modulates the electrical activity of neurons, moderately changing the resting potential, action potential, and impulse frequency in a manner interpreted as activating action.<\/p>\n

Nerve Regeneration<\/strong><\/h3>\n

Research has demonstrated Cortagen’s effects on the restoration of injured nerve function. Studies on the effect of tetrapeptide Cortagen on regeneration of sciatic nerve have shown its capacity to support structural and functional recovery of peripheral nerve tissue.<\/p>\n

Gene Expression Modulation<\/strong><\/h3>\n

Microarray studies have elucidated the effect of Cortagen on gene expression in mouse heart, facilitating understanding of the mechanisms responsible for this peptide’s biological effects. Additionally, Cortagen has been shown to modulate the expression of IL-2 gene in vivo in cells of some hypothalamic structures. Moreover, Cortagen influences free-radical processes, decreasing the content of lipid peroxidation products and reducing oxidative modification of proteins.<\/p>\n

Why Is Cortagen Studied in Switzerland?<\/strong><\/h2>\n

Primarily, researchers study Cortagen because it represents a well-characterized tetrapeptide bioregulator that enables investigation of neuroprotection, epigenetic regulation, and tissue-specific gene expression. In fact, this compound offers a focused tool for studying the molecular mechanisms underlying brain function, nerve regeneration, and age-related cognitive decline.<\/p>\n

Research has demonstrated Cortagen’s relevance across multiple domains. The evidence base for Cortagen consists of approximately 13 total studies with only one human study and no randomized controlled trials. These studies have examined Cortagen’s effects on: structural and functional posttraumatic recovery of peripheral nerve tissue; neuroprotection in ischemia-reperfusion models; gene expression in neural, cardiac, and immune tissues through epigenetic chromatin remodeling; and chromatin decondensation and ribosomal gene activation.<\/p>\n

Cortagen has also been shown to accelerate the recovery of disturbed individual behavior of ischemic rats with different resistance to hypoxia. Furthermore, studies in Drosophila models for neurodegenerative disorders have explored Cortagen’s therapeutic activity. Ultimately, researchers who buy Cortagen 20mg in Switzerland gain access to a comprehensive research tool for investigating neuroprotection, gene regulation, and nervous system biology.<\/p>\n

Cortagen Research Areas in Laboratory Studies<\/strong><\/h2>\n\n\n\n\n\n\n\n\n\n\n\n
Research Area<\/th>\nFocus<\/th>\nEvidence Level<\/th>\n<\/tr>\n<\/thead>\n
Neuroprotection<\/td>\nIschemia-reperfusion injury, stroke models, infarct volume reduction<\/td>\nAnimal \/ Preclinical<\/td>\n<\/tr>\n
Chromatin Remodeling<\/td>\nDeheterochromatinization, ribosomal gene activation, epigenetic regulation<\/td>\nMechanistic<\/td>\n<\/tr>\n
Nerve Regeneration<\/td>\nSciatic nerve repair, peripheral nerve recovery, posttraumatic recovery<\/td>\nAnimal \/ Preclinical<\/td>\n<\/tr>\n
Gene Expression Modulation<\/td>\nCardiac gene expression, IL-2 expression, tissue-specific regulation<\/td>\nMechanistic \/ In Vivo<\/td>\n<\/tr>\n
Neuronal Activity<\/td>\nResting potential modulation, action potential, impulse frequency<\/td>\nMechanistic \/ In Vitro<\/td>\n<\/tr>\n
Cognitive and Neurodegenerative Research<\/td>\nAge-related cognitive decline, Drosophila neurodegeneration models<\/td>\nPreclinical<\/td>\n<\/tr>\n
Free-Radical Processes<\/td>\nLipid peroxidation reduction, oxidative protein modification<\/td>\nMechanistic \/ In Vivo<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Cortagen Compared With Related Research Compounds<\/strong><\/h2>\n\n\n\n\n\n\n\n\n
Compound<\/th>\nResearch Focus<\/th>\nMechanism \/ Target<\/th>\nKey Difference<\/th>\n<\/tr>\n<\/thead>\n
Cortagen (AEDP)<\/td>\nBrain and CNS, neuroprotection, nerve regeneration<\/td>\nChromatin remodeling, gene expression modulation<\/td>\nTetrapeptide; Ala-Glu-Asp-Pro sequence; CNS-specific bioregulator<\/td>\n<\/tr>\n
Epithalon (AEDG)<\/td>\nPineal gland, aging, circadian rhythms<\/td>\nDNA interaction, telomerase activation<\/td>\nDifferent target tissue; Ala-Glu-Asp-Gly sequence<\/td>\n<\/tr>\n
Bronchogen (AEDL)<\/td>\nBronchial epithelium, pulmonary research<\/td>\nDNA interaction, gene expression modulation<\/td>\nDifferent target tissue; Ala-Glu-Asp-Leu sequence<\/td>\n<\/tr>\n
Cardiogen (AEDR)<\/td>\nCardiac tissue, cardiomyocyte function<\/td>\nDNA interaction, chromatin modulation<\/td>\nDifferent target tissue; Ala-Glu-Asp-Arg sequence<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Comparatively, Cortagen differs from other Khavinson peptide bioregulators in its tissue specificity and amino acid sequence. On the one hand, Epithalon (Ala-Glu-Asp-Gly) targets pineal gland function and aging-related processes. On the other hand, Cortagen (Ala-Glu-Asp-Pro) is specifically designed for brain and central nervous system research, with demonstrated effects on neuroprotection, chromatin remodeling, and nerve regeneration. In contrast, Bronchogen targets bronchial epithelium while Cardiogen focuses on cardiac tissue.<\/p>\n

Research Applications for Cortagen in Switzerland<\/strong><\/h2>\n

Scientists have investigated Cortagen across several research domains:<\/p>\n